Newly Recruiting Clinical Trials

Shows clinical trials that have started to recruit within the selected timeframe

Search Results

There are 7 clinical trial(s) matching the criteria.

A Two-Part, Multi-Center, Prospective, Phase 2/3 Clinical Study to Evaluate the Safety and Efficacy of GLASSIA as an Add-On Biopharmacotherapy to Conventional Steroid Treatment in Subjects with Acute Graft-Versus-Host Disease with Lower Gastrointestinal Involvement

Investigator: Krishna Komanduri

Institutional Protocol #: 20160975

National Clinical Trials Identifier: NCT02956122

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase II/III

Enrolling Since: 4/14/2017

C-700-01: A Phase 1 / 2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second-Line Cervical Cancer

Investigator: Breelyn Wilky

Institutional Protocol #: 20170076

National Clinical Trials Identifier: NCT03104699

Division: Cancer Center

Therapeutic Area: Bone and Soft Tissue Cancers

Phase: Phase I/II

Enrolling Since: 4/10/2017